Published in FDA Law Weekly, August 12th, 2004
"Specificity and memory are the defining characteristics of adaptive immune responses. Vaccines are predicated on the existence of immune memory, and the robustness of immune memory is a primary determinant of vaccine efficacy," scientists in the United States report.
"How is immune memory maintained'" asked Shane Crotty at the La Jolla Institute for Allergy and Immunology and Rafi Ahmed at Emory University. "Much progress has been made in this area over the past several years, and new human studies have added key insights into the longevity of B and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
Source: FDA Law Weekly (2004-08-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.